Source: DRUG STORE NEWS

Cadence Pharmaceuticals: Mallinckrodt completes acquisition of Cadence Pharmaceuticals

Ryan ChavisMallinckrodt, a specialty pharmaceuticals company, announced the completion of its acquisition of Cadence Pharmaceuticals for approximately $1.4 billion.read more

Read full article »
Cadence Pharmaceuticals's Competitors | Cadence Pharmaceuticals's News | Cadence Pharmaceuticals's Financials
Stay up-to-date with the latest news on Cadence Pharmaceuticals
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
Theodore Schroeder's photo - President & CEO of Cadence Pharmaceuticals

President & CEO

Theodore Schroeder

CEO Approval Rating

91/100

Read more
Stay up-to-date with the latest news on Cadence Pharmaceuticals